5 Worst Stock Picks of Cathie Wood

3. Chemomab Therapeutics Ltd. (NASDAQ:CMMB)

Number of Hedge Fund Holders: 3 

Decline in Share Price in 2021: 81%

Chemomab Therapeutics Ltd. (NASDAQ:CMMB) operates as a biotech firm. Elite hedge funds have been attracted by the drug pipeline of the company in recent months. Among the hedge funds being tracked by Insider Monkey, New York-based firm OrbiMed Advisors is a leading shareholder in Chemomab Therapeutics Ltd. (NASDAQ:CMMB) with 2.5 million shares worth more than $28 million. 

Chemomab Therapeutics Ltd. (NASDAQ:CMMB) is a new holding in the ARK portfolio. The fund purchased a stake in the company between June and September this year. The stake consists of 180,523 shares worth $2 million.